ArticleClinical and vaccine immunology : CVI2007

Synthetic Toll-like receptor 4 agonist enhances vaccine efficacy in an experimental model of toxic shock syndrome.

Garry L Morefield et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.